What does CUSIP 71426V108 represent in this 13F holders report?

CUSIP 71426V108 is the security identifier for PTX - PERNIX THERAPEUTICS HLDGS IN - COM used to aggregate holder disclosures.

How many institutions held PTX - PERNIX THERAPEUTICS HLDGS IN - COM in Q3 2016?

40 institutional investors reported PTX - PERNIX THERAPEUTICS HLDGS IN - COM for Q3 2016. Use the holders table for investor-level position and value details.

PERNIX THERAPEUTICS HLDGS IN - COM (PTX)

CUSIP: 71426V108

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class: Equity / COM
Total 13F shares: 12,908,295
Share change: +583,005
Total reported value: $8,022,000
Price per share: $0.62
Number of holders: 40
Value change: +$840,727
Number of buys: 16
Number of sells: 28

Quarterly Holders Quick Answers

What is CUSIP 71426V108?
CUSIP 71426V108 identifies PTX - PERNIX THERAPEUTICS HLDGS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2016
Previous quarter: Q2 2016

Recent filing periods for CUSIP 71426V108:

Q4 2016 Q3 2016 Q2 2016 Q1 2016 Q4 2015 Q3 2015 Q2 2015 Q1 2015

Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM (PTX) as of Q3 2016

As of 30 Sep 2016, PERNIX THERAPEUTICS HLDGS IN - COM (PTX) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,908,295 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, Aisling Capital LLC, BlackRock Institutional Trust Company, N.A., ORBIMED ADVISORS LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, GSA CAPITAL PARTNERS LLP, Jefferies Group LLC, and SEARLE & CO.. This page lists 40 institutional shareholders reporting positions in this security for the Q3 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.